Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Pelicci, PG' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 157 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Salcini, AE; Hilliard, MA; Croce, A; Arbucci, S; Luzzi, P; Tacchetti, C; Daniell, L; De Camilli, P; Pelicci, PG; Di Fiore, PP; Bazzicalupo, P
      The Eps15 C-elegans homologue EHS-1 is implicated in synaptic vesicle recycling

      NATURE CELL BIOLOGY
    2. Pearson, M; Pelicci, PG
      PML interaction with p53 and its role in apoptosis and replicative senescence

      ONCOGENE
    3. Alcalay, M; Orleth, A; Sebastiani, C; Meani, N; Chiaradonna, F; Casciari, C; Sciurpi, MT; Gelmetti, V; Riganelli, D; Minucci, S; Fagioli, M; Pelicci, PG
      Common themes in the pathogenesis of acute myeloid leukemia

      ONCOGENE
    4. Malabarba, MG; Milia, E; Faretta, M; Zamponi, R; Pelicci, PG; Di Fiore, PP
      A repertoire library that allows the selection of synthetic SH2s with altered binding specificities

      ONCOGENE
    5. Archer, T; Baylin, S; Hansen, J; Hayes, J; Pelicci, PG; Robertson, K; Stunnenberg, H; Urnov, F; Wade, P
      Dr Alan P Wolffe 1959-2000 - Obituary

      ONCOGENE
    6. Minucci, S; Nervi, C; Lo Coco, F; Pelicci, PG
      Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?

      ONCOGENE
    7. Zhang, JS; Hug, BA; Huang, EY; Chen, CW; Gelmetti, V; Maccarana, M; Minucci, S; Pelicci, PG; Lazar, MA
      Oligomerization of ETO is obligatory for corepressor interaction

      MOLECULAR AND CELLULAR BIOLOGY
    8. Reymond, A; Meroni, G; Fantozzi, A; Merla, G; Cairo, S; Luzi, L; Riganelli, D; Zanaria, E; Messali, S; Cainarca, S; Guffanti, A; Minucci, S; Pelicci, PG; Ballabio, A
      The tripartite motif family identifies cell compartments

      EMBO JOURNAL
    9. Faretta, M; Di Croce, L; Pelicci, PG
      Effects of the acute myeloid leukemia-associated fusion proteins on nuclear architecture

      SEMINARS IN HEMATOLOGY
    10. Nervi, C; Borello, U; Fazi, F; Buffa, V; Pelicci, PG; Cossu, G
      Inhibition of histone deacetylase activity by trichostatin A modulates gene expression during mouse embryogenesis without apparent toxicity

      CANCER RESEARCH
    11. Ferrara, FF; Fazi, F; Bianchini, A; Padula, F; Gelmetti, V; Minucci, S; Mancini, M; Pelicci, PG; Lo Coco, F; Nervi, C
      Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia

      CANCER RESEARCH
    12. Minucci, S; Maccarana, M; Cioce, M; De Luca, P; Gelmetti, V; Segalla, S; Di Croce, L; Giavara, S; Matteucci, C; Gobbi, A; Bianchini, A; Colombo, E; Schiavoni, I; Badaracco, G; Hu, X; Lazar, MA; Landsberger, N; Nervi, C; Pelicci, PG
      Oligomerization of RAR and AML1 transcription factors as a novel mechanismof oncogenic activation

      MOLECULAR CELL
    13. Luzi, L; Confalonieri, S; Di Fiore, PP; Pelicci, PG
      Evolution of Shc functions from nematode to human

      CURRENT OPINION IN GENETICS & DEVELOPMENT
    14. Vannucchi, S; Percario, ZA; Chiantore, MV; Matarrese, P; Chelbi-Alix, MK; Fagioli, M; Pelicci, PG; Malorni, W; Fiorucci, G; Romeo, G; Affabris, E
      Interferon-beta induces S phase slowing via up-regulated expression of PMLin squamous carcinoma cells

      ONCOGENE
    15. Pearson, M; Carbone, R; Sebastiani, C; Cioce, M; Fagioli, M; Saito, S; Higashimoto, Y; Appella, E; Minucci, S; Pandolfi, PP; Pelicci, PG
      PML regulates p53 acetylation and premature senescence induced by oncogenic Ras

      NATURE
    16. Santolini, E; Puri, C; Salcini, AE; Gagliani, MC; Pelicci, PG; Tacchetti, C; Di Fiore, PP
      Numb is an endocytic protein

      JOURNAL OF CELL BIOLOGY
    17. Trinei, M; Lanfrancone, L; Campo, E; Pulford, K; Mason, DY; Pelicci, PG; Falini, B
      A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma

      CANCER RESEARCH
    18. Bonati, A; Carlo-Stella, C; Lunghi, P; Albertini, R; Pinelli, S; Migliaccio, E; Sammarelli, G; Savoldo, B; Tabilio, A; Dall'Aglio, PD; Pelicci, PG
      Selective expression and constitutive phosphorylation of Src-homology-2 and collagen-homology domains proteins in the CD34(+) fraction of chronic myelogenous leukemias

      CANCER RESEARCH
    19. Di Florio, S; Sebastiani, C; Fagioli, M; Di Ianni, M; Alfonsi, D; Venditti, G; Pelicci, PG; Tabilio, A
      Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and enhanced green fluorescence protein genes in primary T lymphocytes

      BRITISH JOURNAL OF HAEMATOLOGY
    20. Grignani, F; Valtieri, M; Gabbianelli, M; Gelmetti, V; Botta, R; Luchetti, L; Masella, B; Morsilli, O; Pelosi, E; Samoggia, P; Pelicci, PG; Peschle, C
      PML/RAR alpha fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype

      BLOOD
    21. Minucci, S; Pelicci, PG
      Retinoid receptors in health and disease: co-regulators and the chromatin connection

      SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
    22. Torrisi, MR; Lotti, LV; Belleudi, F; Gradini, R; Salcini, AE; Confalonieri, S; Pelicci, PG; Di Fiore, PP
      Eps15 is recruited to the plasma membrane upon epidermal growth factor receptor activation and localizes to components of the endocytic pathway during receptor internalization

      MOLECULAR BIOLOGY OF THE CELL
    23. Grignani, F; Gelmetti, V; Fanelli, M; Rogaia, D; De Matteis, S; Ferrara, FF; Bonci, D; Grignani, F; Nervi, C; Pelicci, PG
      Formation of PML/RAR alpha high molecular weight nuclear complexes throughthe PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response

      ONCOGENE
    24. Casini, T; Pelicci, PG
      A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest

      ONCOGENE
    25. Mozziconacci, ML; Liberatore, C; Grignani, F; Sainty, D; Pelicci, PG; Birg, F; Lafage-Pochitaloff, M
      Atypical response to all-trans retinoic acid in a der(5)t(5;17) acute promyelocytic leukemia

      LEUKEMIA
    26. Benedetti, G; Patoia, L; Giglietti, A; Alessio, M; Pelicci, PG; Grignani, F
      Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients

      BONE MARROW TRANSPLANTATION
    27. Migliaccio, E; Giorgio, M; Mele, S; Pelicci, G; Reboidl, P; Pandolfi, PP; Lanfrancone, L; Pelicci, PG
      The p66(shc) adaptor protein controls oxidative stress response and life span in mammals

      NATURE
    28. Pollock, JL; Westervelt, P; Kurichety, AK; Pelicci, PG; Grisolano, JL; Ley, TJ
      A bcr-3 isoform of RAR alpha-PML potentiates the development of PML-RAR alpha-driven acute promyelocytic leukemia

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    29. Gottifredi, V; Pelicci, G; Munarriz, E; Maione, R; Pelicci, PG; Amati, P
      Polyomavirus large T antigen induces alterations in cytoplasmic signallingpathways involving Shc activation

      JOURNAL OF VIROLOGY
    30. Doria, M; Salcini, AE; Colombo, E; Parslow, TG; Pelicci, PG; Di Fiore, PP
      The Eps15 homology (EH) domain-based interaction between Eps15 and Hrb connects the molecular machinery of endocytosis to that of nucleocytosolic transport

      JOURNAL OF CELL BIOLOGY
    31. Fanelli, M; Pelicci, PG
      Relationship between degradation of PML-RAR alpha and differentiation - Response

      BLOOD
    32. Falini, B; Pulford, K; Pucciarini, A; Carbone, A; De Wolf-Peeters, C; Cordell, J; Fizzotti, M; Santucci, A; Pelicci, PG; Pileri, S; Campo, E; Ott, G; Delsol, G; Mason, DY
      Lymphomas expressing ALK fusion protein(s) other than NPM-ALK

      BLOOD
    33. Lo Coco, F; Diverio, D; Falini, B; Biondi, A; Nervi, C; Pelicci, PG
      Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia

      BLOOD
    34. Falini, B; Pileri, S; Zinzani, PL; Carbone, A; Zagonel, V; Wolf-Peeters, C; Verhoef, G; Menestrina, F; Todeschini, G; Paulli, M; Lazzarino, M; Giardini, R; Aiello, A; Foss, HD; Araujo, I; Fizzotti, M; Pelicci, PG; Flenghi, L; Martelli, MF; Santucci, A
      ALK(+) lymphoma: Clinico-pathological findings and outcome

      BLOOD
    35. Fanelli, M; Minucci, S; Gelmetti, V; Nervi, C; Gambacorti-Passerini, C; Pelicci, PG
      Constitutive degradation of PML/RAR alpha through the proteasome pathway mediates retinoic acid resistance

      BLOOD
    36. Cordell, JL; Pulford, KAF; Bigerna, B; Roncador, G; Banham, A; Colombo, E; Pelicci, PG; Mason, DY; Falini, B
      Detection of normal and chimeric nucleophosmin in human cells

      BLOOD
    37. REGAZZI MB; RUSSO D; IACONA I; SACCHI S; VISANI G; LAZZARINO N; AVVISATI G; PELICCI PG; DASTOLI G; GRANDI C; SPREAFICO S; GRATTONI R; GALIENI P; RUPOLI S; MAIOLO AM; GUERRA E; LIBERATI AM
      TIME-DEPENDENT KINETICS OF TRETINOIN IN CHRONIC MYELOGENOUS LEUKEMIA DURING INTERMITTENT DOSE SCHEDULING - 1 WEEK ON 1 WEEK OFF

      Clinical drug investigation
    38. MOZZICONACCI MJ; LIBERATORE C; BRUNEL V; GRIGNANI F; ARNOULET C; FERRUCCI PF; FERNANDEZ F; SAINTY D; PELICCI PG; BIRG F; LAFAGEPOCHITALOFF M
      IN-VITRO RESPONSE TO ALL-TRANS-RETINOIC ACID OF ACUTE PROMYELOCYTIC LEUKEMIAS WITH NONRECIPROCAL PML RARA OR RARA/PML FUSION GENES/

      Genes, chromosomes & cancer
    39. FAGIOLI M; ALCALAY M; TOMASSONI L; FERRUCCI PF; MENCARELLI A; RIGANELLI D; GRIGNANI F; POZZAN T; NICOLETTI I; GRIGNANI F; PELICCI PG
      COOPERATION BETWEEN THE RING-B2 AND COILED-COIL DOMAINS OF PML IS NECESSARY FOR ITS EFFECTS ON CELL-SURVIVAL(B1)

      Oncogene
    40. RUTHARDT M; ORLETH A; TOMASSONI L; PUCCETTI E; RIGANELLI D; ALCALAY M; MANNUCCI R; NICOLETTI I; GRIGNANI F; FAGIOLI M; PELICCI PG
      THE ACUTE PROMYELOCYTIC LEUKEMIA SPECIFIC PML AND PLZF PROTEINS LOCALIZE TO ADJACENT AND FUNCTIONALLY DISTINCT NUCLEAR-BODIES

      Oncogene
    41. PELLEGRINI C; SANTOLINI E; ORVIETO E; PELICCI PG; DIFIORE PP; VIALE G
      EXPRESSION OF HUMAN NUMB, A PROTEIN THAT SPECIFIES CELL FATE, IN INVASIVE BREAST CARCINOMAS

      Modern pathology
    42. RUSSO D; REGAZZI M; SACCHI S; VISANI C; LAZZARINO M; AVVISATI G; PELICCI PG; DASTOLI G; GRANDI C; IACONA I; CANDONI A; GRATTONI R; GALIENI P; RUPOLI S; LIBERATI AM; MAIOLO AT
      ALL-TRANS-RETINOIC ACID (ATRA) IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA IN THE CHRONIC PHASE

      Leukemia
    43. TESTA U; GRIGNANI F; HASSAN HJ; ROGAIA D; MASCIULLI R; GELMETTI V; GUERRIERO R; MACIOCE G; LIBERATORE C; BARBERI T; MARIANI G; PELICCI PG; PESCHLE C
      TERMINAL MEGAKARYOCYTIC DIFFERENTIATION OF TF-1 CELLS IS INDUCED BY PHORBOL ESTERS AND THROMBOPOIETIN AND IS BLOCKED BY EXPRESSION OF PML RAR-ALPHA FUSION PROTEIN/

      Leukemia
    44. GRIGNONI F; VALTIERI M; GABBIANELLI M; GELMETTI V; LUCHETTI L; MASELLO B; PELOSI E; SAMOGGIA P; ZANETTI C; BOTTA R; MORSILLI O; PELICCI PG; PESCHLE C
      THE PROMYELOCYTIC LEUKEMIA PHENOTYPE IS DIRECTLY DETERMINED BY PML RAR-ALPHA FUSION PROTEIN EXPRESSION IN NORMAL HUMAN HEMATOPOIETIC PROGENITORS/

      Experimental hematology
    45. ALCALAY M; TOMASSONI L; COLOMBO E; STOLDT S; GRIGNANI F; FAGIOLI M; SZEKELY L; HELIN K; PELICCI PG
      THE PROMYELOCYTIC LEUKEMIA GENE-PRODUCT (PML) FORMS STABLE COMPLEXES WITH THE RETINOBLASTOMA PROTEIN

      Molecular and cellular biology
    46. GELMETTI V; ZHANG JS; FANELLI M; MINUCCI S; PELICCI PG; LAZAR MA
      ABERRANT RECRUITMENT OF THE NUCLEAR RECEPTOR COREPRESSOR-HISTONE DEACETYLASE COMPLEX BY THE ACUTE MYELOID-LEUKEMIA FUSION PARTNER ETO

      Molecular and cellular biology (Print)
    47. Paoluzi, S; Castagnoli, L; Lauro, I; Salcini, AE; Coda, L; Fre', S; Confalonieri, S; Pelicci, PG; Di Fiore, PP; Cesareni, G
      Recognition specificity of individual EH domains of mammals and yeast

      EMBO JOURNAL
    48. CATTANEO E; PELICCI PG
      EMERGING ROLES FOR SH2 PTB-CONTAINING SHC ADAPTER PROTEINS IN THE DEVELOPING MAMMALIAN BRAIN/

      Trends in neurosciences
    49. GRIGNANI F; DEMATTEIS S; NERVI C; TOMASSONI L; GELMETTI V; CIOCE M; FANELLI M; RUTHARDT M; FERRARA FF; ZAMIR I; SEISER C; GRIGNANI F; LAZAR MA; MINUCCI S; PELICCI PG
      FUSION PROTEINS OF THE RETINOIC ACID RECEPTOR-ALPHA RECRUIT HISTONE DEACETYLASE IN PROMYELOCYTIC LEUKEMIA

      Nature
    50. PELLEGRINI C; SANTOLINI E; ORVIETO E; PELICCI PG; DIFIORE PP; VIALE G
      EXPRESSION OF HUMAN NUMB, A PROTEIN THAT SPECIFIES CELL FATE, IN INVASIVE BREAST CARCINOMAS

      Laboratory investigation
    51. TESTA U; GRIGNANI F; SAMOGGIA P; ZANETTI C; RICCIONI R; LOCOCO F; DIVERIO D; FELLI N; PASSERINI CG; GRELL M; PELICCI PG; PESCHLE C
      THE PML RAR-ALPHA FUSION PROTEIN INHIBITS TUMOR NECROSIS FACTOR-ALPHA-INDUCED APOPTOSIS IN U937 CELLS AND ACUTE PROMYELOCYTIC LEUKEMIA BLASTS/

      The Journal of clinical investigation
    52. CODA L; SALCINI AE; CONFALONIERI S; PELICCI G; SORKINA T; SORKIN A; PELICCI PG; DIFIORE PP
      EPS15R IS A TYROSINE KINASE SUBSTRATE WITH CHARACTERISTICS OF A DOCKING PROTEIN POSSIBLY INVOLVED IN COATED PITS-MEDIATED INTERNALIZATION

      The Journal of biological chemistry
    53. PACINI S; ULIVIERI C; MADDALENA M; DISOMMA MM; ISACCHI A; LANFRANCONE L; PELICCI PG; TELFORD JL; BALDARI CT
      TYROSINE-474 OF ZAP-70 IS REQUIRED FOR ASSOCIATION WITH THE SHC ADAPTER AND FOR T-CELL ANTIGEN RECEPTOR-DEPENDENT GENE ACTIVATION

      The Journal of biological chemistry
    54. GRIGNANI F; KINSELLA T; MENCARELLI A; VALTIERI M; RIGANELLI D; GRIGNANI F; LANFRANCONE L; PESCHLE C; NOLAN GP; PELICCI PG
      HIGH-EFFICIENCY GENE-TRANSFER AND SELECTION OF HUMAN HEMATOPOIETIC PROGENITOR CELLS WITH A HYBRID EBV RETROVIRAL VECTOR EXPRESSING THE GREEN FLUORESCENCE PROTEIN/

      Cancer research
    55. NERVI C; FERRARA FF; FANELLI M; RIPPO MR; TOMASSINI B; FERRUCCI PF; RUTHARDT M; GELMETTI V; GAMBACORTIPASSERINI C; DIVERIO D; GRIGNANI F; PELICCI PG; TESTI R
      CASPASES MEDIATE RETINOIC ACID-INDUCED DEGRADATION OF THE ACUTE PROMYELOCYTIC LEUKEMIA PML RAR-ALPHA FUSION PROTEIN/

      Blood
    56. DIVERIO D; ROSSI V; AVVISATI G; DESANTIS S; PISTILLI A; PANE F; SAGLIO G; MARTINELLI G; PETTI MC; SANTORO A; PELICCI PG; MANDELLI F; BIONDI A; LOCOCO F
      EARLY DETECTION OF RELAPSE BY PROSPECTIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION ANALYSIS OF THE PML RAR-ALPHA FUSION GENE IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA ENROLLED IN THE GIMEMA-AIEOP MULTICENTER AIDA TRIAL/

      Blood
    57. FALINI B; BIGERNA B; FIZZOTTI M; PULFORD K; PILERI SA; DELSOL G; CARBONE A; PAULLI M; MAGRINI U; MENESTRINA F; GIARDINI R; PILOTTI S; MEZZELANI A; UGOLINI B; BILLI M; PUCCIARINI A; PACINI R; PELICCI PG; FLENGHI L
      ALK EXPRESSION DEFINES A DISTINCT GROUP OF T NULL LYMPHOMAS (ALK LYMPHOMAS) WITH A WIDE MORPHOLOGICAL SPECTRUM/

      The American journal of pathology
    58. DIFIORE PP; PELICCI PG; SORKIN A
      EH - A NOVEL PROTEIN-PROTEIN INTERACTION DOMAIN POTENTIALLY INVOLVED IN INTRACELLULAR SORTING

      Trends in biochemical sciences
    59. PELICCI PG
      CYTOPLASMIC TRANSDUCTION MECHANISMS OF MITOGENIC SIGNALS

      European journal of cancer
    60. TORTORA G; DAMIANO V; BIANCO C; BALDASSARRE G; BIANCO AR; LANFRANCONE L; PELICCI PG; CIARDIELLO F
      THE RI-ALPHA SUBUNIT OF PROTEIN-KINASE-A (PKA) BINDS TO GRB2 AND ALLOWS PKA INTERACTION WITH THE ACTIVATED EGF-RECEPTOR

      Oncogene
    61. SALCINI AE; CONFALONIERI S; DORIA M; SANTOLINI E; TASSI E; MINENKOVA O; CESARENI G; PELICCI PG; DIFIORE PP
      BINDING-SPECIFICITY AND IN-VIVO TARGETS OF THE EH DOMAIN, A NOVEL PROTEIN-PROTEIN INTERACTION MODULE

      Genes & development
    62. SACCHI S; RUSSO D; AVVISATI G; DASTOLI G; LAZZARINO M; PELICCI PG; BONORA MR; VISANI G; GRASSI C; IACONA I; LUZZI L; VANZANELLI P
      ALL-TRANS-RETINOIC ACID IN HEMATOLOGICAL MALIGNANCIES - AN UPDATE

      Haematologica
    63. TESTA U; GRIGNANI F; SAMOGGIA P; MASCIULLI R; ZANETTI C; RICCIONI R; PASSERINI CG; GRELL M; PELICCI PG; PESCHLE C
      THE ACUTE PROMYELOCYTIC LEUKEMIA-SPECIFIC PML RAR-ALPHA FUSION PROTEIN REDUCES SENSITIVITY TO APOPTOSIS UPON TNF-ALPHA STIMULATION/

      Experimental hematology
    64. RUTHARDT M; TESTA U; NERVI C; FERRUCCI PF; GRIGNANI F; PUCCETTI E; GRIGNANI F; PESCHLE C; PELICCI PG
      OPPOSITE EFFECTS OF THE ACUTE PROMYELOCYTIC LEUKEMIA PML-RETINOIC ACID RECEPTOR-ALPHA (RAR-ALPHA) AND PLZF-RAR-ALPHA FUSION PROTEINS ON RETINOIC ACID SIGNALING

      Molecular and cellular biology
    65. MIGLIACCIO E; MELE S; SALCINI AE; PELICCI G; LAI KMV; SUPERTIFURGA G; PAWSON T; DIFIORE P; LANFRANCONE L; PELICCI PG
      OPPOSITE EFFECTS OF THE P52(SHC) P46(SHC) AND P66(SHC) SPLICING ISOFORMS ON THE EGF RECEPTOR-MAP KINASE-FOS SIGNALING PATHWAY/

      EMBO journal
    66. GARAU D; CARLOSTELLA C; REGAZZI E; SAVOLDO B; RIZZOLI V; PELICCI PG; LANFRANCONE L; DOTTI GP; SPINELLI O; BARBUI T; RAMBALDI A
      SHC OVEREXPRESSION PREVENTS APOPTOSIS AND INDUCES HYPERSENSITIVITY TOGM-CSF OF THE GM-CSF-DEPENDENT AML CELL-LINE GF-D8

      European journal of cell biology
    67. BROWN D; KOGAN S; LAGASSE E; WEISSMAN I; ALCALAY M; PELICCI PG; ATWATER S; BISHOP JM
      A PMLRAR-ALPHA TRANSGENE INITIATES MURINE ACUTE PROMYELOCYTIC LEUKEMIA

      Proceedings of the National Academy of Sciences of the United Statesof America
    68. FERRUCCI PF; GRIGNANI F; PEARSON M; FAGIOLI M; NICOLETTI I; PELICCI PG
      CELL-DEATH INDUCTION BY THE ACUTE PROMYELOCYTIC LEUKEMIA-SPECIFIC PMLRAR-ALPHA FUSION PROTEIN/

      Proceedings of the National Academy of Sciences of the United Statesof America
    69. HE LZ; TRIBIOLI C; RIVI R; PERUZZI D; PELICCI PG; SOARES V; CATTORETTI G; PANDOLFI PP
      ACUTE-LEUKEMIA WITH PROMYELOCYTIC FEATURES IN PML RAR-ALPHA TRANSGENIC MICE/

      Proceedings of the National Academy of Sciences of the United Statesof America
    70. DENTE L; VETRIANI C; ZUCCONI A; PELICCI G; LANFRANCONE L; PELICCI PG; CESARENI G
      MODIFIED PHAGE PEPTIDE LIBRARIES AS A TOOL TO STUDY SPECIFICITY OF PHOSPHORYLATION AND RECOGNITION OF TYROSINE-CONTAINING PEPTIDES

      Journal of Molecular Biology
    71. GIORDANO V; DEFALCO G; CHIARI R; QUINTO I; PELICCI PG; BARTHOLOMEW L; DELMASTRO P; GADINA M; SCALA G
      SHC MEDIATES IL-6 SIGNALING BY INTERACTING WITH GP130 AND JAK2 KINASE

      The Journal of immunology
    72. CASINI T; GRIGNANI F; PELICCI PG
      GENETICS OF APL AND THE MOLECULAR-BASIS OF RETINOIC ACID TREATMENT

      International journal of cancer
    73. ROGAIA D; GRIGNANI F; CARBONE R; RIGANELLI D; LOCOCO F; NAKAMURA T; CROCE CM; DIFIORE PP; PELICCI PG
      THE LOCALIZATION OF THE HRX ALL1 PROTEIN TO SPECIFIC NUCLEAR SUBDOMAINS IS ALTERED BY FUSION WITH ITS EPS15 TRANSLOCATION PARTNER/

      Cancer research
    74. CARBONE R; FRE S; IANNOLO G; BELLEUDI F; MANCINI P; PELICCI PG; TORRISI MR; DIFIORE PP
      EPS15 AND EPS15R ARE ESSENTIAL COMPONENTS OF THE ENDOCYTIC PATHWAY

      Cancer research
    75. IANNOLO G; SALCINI AE; GAIDAROV I; GOODMAN OB; BAULIDA J; CARPENTER G; PELICCI PG; DIFIORE PP; KEEN JH
      MAPPING OF THE MOLECULAR DETERMINANTS INVOLVED IN THE INTERACTION BETWEEN EPS15 AND AP-2

      Cancer research
    76. MANDELLI F; DIVERIO D; AVVISATI G; LUCIANO A; BARBUI T; BERNASCONI C; BROCCIA G; CERRI R; FALDA M; FIORITONI G; LEONI F; LISO V; PETTI MC; RODEGHIERO F; SAGLIO G; VEGNA ML; VISANI G; JEHN U; WILLEMZE R; MUUS P; PELICCI PG; BIONDI A; LOCOCO F
      MOLECULAR REMISSION IN PML RAR-ALPHA-POSITIVE ACUTE PROMYELOCYTIC LEUKEMIA BY COMBINED ALL-TRANS-RETINOIC ACID AND IDARUBICIN (AIDA) THERAPY/

      Blood
    77. BENEDETTI L; LEVIN AA; SCICCHITANO BM; GRIGNANI F; ALLENBY G; DIVERIO D; LOCOCO F; AVVISATI G; RUTHARDT M; ADAMO S; PELICCI PG; NERVI C
      CHARACTERIZATION OF THE RETINOID-BINDING PROPERTIES OF THE MAJOR FUSION PRODUCTS PRESENT IN ACUTE PROMYELOCYTIC LEUKEMIA-CELLS

      Blood
    78. BONATI A; LUNGHI P; ALBERTINI R; PINELLI S; MIGLIACCIO E; TABILIO A; CARLOSTELLA C; RIZZOLI V; DALLAGLIO PP; PELICCI PG
      ACTIVATION OF SHC AND ERK KINASE PATHWAYS IN ACUTE MYELOGENOUS LEUKEMIA

      Blood
    79. FANELLI M; NERVI C; PELICCI PG; GAMBACORTIPASSERINI C
      CONSTITUTIVE DEGRADATION OF THE PML RAR-ALPHA PROTEIN IS PRESENT IN RETINOIC ACID (RA)-RESISTANT ACUTE PROMYELOCYTIC LEUKEMIA-CELLS AND INVOLVES THE PROTEASOME PROTEOLYTIC PATHWAY/

      Blood
    80. BONATI A; CARLOSTELLA C; LUNGHI P; ALBERTINI R; PINELLI S; MIGLIACCIO E; SAMMARELLI G; SAVOLDO B; TABILIO A; RIZZOLI V; DALLAGLIO PP; PELICCI PG
      SHC PROTEINS PHOSPHORYLATION IN CHRONIC MYELOGENOUS LEUKEMIA

      Blood
    81. RUTHARDT M; ORLETH A; TOMASSONI L; PUCCETTI E; RIGANELLI D; ALCALAY M; MANNUCCI R; NICOLETTI I; GRIGNANI F; FAGIOLI M; HOELZER D; PELICCI PG
      THE ACUTE PROMYELOCYTIC LEUKEMIA SPECIFIC PML AND PLZF PROTEINS LOCALIZE TO ADJACENT AND FUNCTIONALLY DISTINCT NUCLEAR-BODIES

      Blood
    82. LOCOCO F; DIVERIO D; AVVISATI G; LUCIANO A; DESANTIS S; SANTORO A; PANE F; MARTINELLI G; PELICCI PG; VEGNA ML; SAGLIO G; BIONDI A; MANDELLI F
      PROSPECTIVE RT-PCR MONITORING OF MINIMAL RESIDUAL DISEASE IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS ENROLLED IN THE MULTICENTRIC GIMEMA-AIEOP AIDA TRIAL

      Blood
    83. FALINI B; FLENGHI L; FAGIOLI M; LOCOCO F; CORDONE I; DIVERIO D; PASQUALUCCI L; BIONDI A; RIGANELLI D; ORLETH A; LISO A; MARTELLI MF; PELICCI PG; PILERI S
      IMMUNOCYTOCHEMICAL DIAGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA (M3) WITH THE MONOCLONAL-ANTIBODY PG-M3 (ANTI-PML)

      Blood
    84. GRISOLANO JL; WESSELSCHMIDT RL; PELICCI PG; LEY TJ
      ALTERED MYELOID DEVELOPMENT AND ACUTE-LEUKEMIA IN TRANSGENIC MICE EXPRESSING PML-RAR-ALPHA UNDER CONTROL OF CATHEPSIN-G REGULATORY SEQUENCES

      Blood
    85. GRIGNANI F; RUTHARDT M; TESTA U; ROGAIA D; FERRUCCI PF; GELMETTI V; FAGIOLI M; ALCALAY M; GRIGNANI F; NICOLETTI I; PESCHLE C; PELICCI PG
      MOLECULAR MECHANISMS OF THE EFFECTS ON DIFFERENTIATION BY THE PROMYELOCYTIC LEUKEMIA PML RARA PROTEIN/

      Molecular biology of the cell
    86. BRUNEL V; LAFAGEPOCHITALOFF M; ALCALAY M; PELICCI PG; BIRG F
      VARIANT AND MASKED TRANSLOCATIONS IN ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia & lymphoma
    87. MILIA E; DISOMMA MM; BALDONI F; CHIARI R; LANFRANCONE L; PELICCI PG; TELFORD JL; BALDARI CT
      THE AMINOTERMINAL PHOSPHOTYROSINE BINDING DOMAIN OF SHC ASSOCIATES WITH ZAP-70 AND MEDIATES TCR DEPENDENT GENE ACTIVATION

      Oncogene
    88. PELICCI G; DENTE L; DEGIUSEPPE A; VERDUCCIGALLETTI B; GIULI S; MELE S; VETRIANI C; GIORGIO M; PANDOLFI PP; CESARENI G; PELICCI PG
      A FAMILY OF SHC RELATED PROTEINS WITH CONSERVED PTB, CH1 AND SH2 REGIONS

      Oncogene
    89. BRIZZI MF; DENTELLI P; LANFRANCONE L; ROSSO A; PELICCI PG; PEGORARO L
      DISCRETE PROTEIN INTERACTIONS WITH THE GRB2 C-CBL COMPLEX IN SCF-MEDIATED AND TPO-MEDIATED MYELOID CELL-PROLIFERATION/

      Oncogene
    90. RAELSON JV; NERVI C; ROSENAUER A; BENEDETTI L; MONCZAK Y; PELICCI PG; MILLER WH
      THE PMR RAR-ALPHA ONCOPROTEIN IS A DIRECT MOLECULAR TARGET OF RETINOIC ACID (RA) IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) CELLS/

      Journal of clinical oncology
    91. RUSSO D; IACONA I; REGAZZIBONORA M; LAZZARINO M; SACCHI S; AVVISATI G; VISANI G; PELICCI PG; DASTOLI G; GRASSI C; FOWST C
      PHARMACOKINETIC PROFILE OF ALL-TRANS-RETINOIC ACID (ATRA) INTERMITTENTLY ADMINISTERED IN DIFFERENT HEMATOLOGIC DISEASES

      Experimental hematology
    92. LOTTI LV; LANFRANCONE L; MIGLIACCIO E; ZOMPETTA C; PELICCI G; SALCINI AE; FALINI B; PELICCI PG; TORRISI MR
      SHC PROTEINS ARE LOCALIZED ON ENDOPLASMIC-RETICULUM MEMBRANES AND AREREDISTRIBUTED AFTER TYROSINE KINASE RECEPTOR ACTIVATION

      Molecular and cellular biology
    93. CHEN YH; GRALL D; SALCINI AE; PELICCI PG; POUYSSEGUR J; VANOBBERGHENSCHILLING E
      SHC ADAPTER PROTEINS ARE KEY TRANSDUCERS OF MITOGENIC SIGNALING MEDIATED BY THE G-PROTEIN-COUPLED THROMBIN RECEPTOR

      EMBO journal
    94. GRIGNANI F; TESTA U; ROGAIA D; FERRUCCI PF; SAMOGGIA P; PINTO A; ALDINUCCI D; GELMETTI V; FAGIOLI M; ALCALAY M; SEELER J; GRIGNANI F; NICOLETTI I; PESCHLE C; PELICCI PG
      EFFECTS ON DIFFERENTIATION BY THE PROMYELOCYTIC LEUKEMIA PML RAR-ALPHA PROTEIN DEPEND ON THE FUSION OF THE PML PROTEIN DIMERIZATION AND RAR-ALPHA DNA-BINDING DOMAINS/

      EMBO journal
    95. FOURNIER E; ROSNET O; MARCHETTO S; TURCK CW; ROTTAPEL R; PELICCI PG; BIRNBAUM D; BORG JP
      INTERACTION WITH THE PHOSPHOTYROSINE BINDING DOMAIN PHOSPHOTYROSINE INTERACTING DOMAIN OF SHC IS REQUIRED FOR THE TRANSFORMING ACTIVITY OF THE FLT4/VEGFR3 RECEPTOR TYROSINE KINASES/

      The Journal of biological chemistry
    96. RAELSON JV; NERVI C; ROSENAUER A; BENEDETTI L; MONCZAK Y; PEARSON M; PELICCI PG; MILLER WH
      THE PML RAR-ALPHA ONCOPROTEIN IS A DIRECT MOLECULAR TARGET OF RETINOIC ACID IN ACUTE PROMYELOCYTIC LEUKEMIA-CELLS/

      Blood
    97. SACCHI S; REGAZZI MB; AVVISATI G; DASTOLI G; GALLIENI P; GRASSI C; LAZZARINO M; LIBERATI AM; MAIOLO AT; PELICCI PG; RUPOLI S; VISANI G; RUSSO D
      PHASE I II STUDY OF THE BIOLOGICAL-ACTIVITY OF ALL-TRANS-RETINOIC ACID IN PATIENTS WITH PH(1)(+) CHRONIC MYELOID-LEUKEMIA/

      Blood
    98. STELLA CC; DOTTI GP; SPINELLI O; SAVOLDO B; GARAU D; REGAZZI E; RIZZOLI V; BARBUI T; PELICCI PG; LANFRANCONE L; RAMBALDI A
      SHC OVEREXPRESSION INDUCES SELECTIVE HYPERSENSITIVITY TO GM-CSF AND PREVENTS APOPTOSIS OF THE GM-CSF-DEPENDENT AML CELL-LINE GF-DB

      Blood
    99. BONATI A; CARLOSTELLA C; MIGLIACCIO E; ALBERTINI R; PINELLI S; LUNGHI P; TABILIO A; RIZZOLI V; DALLAGLIO P; PELICCI PG
      PHOSPHORYLATION OF THE SHC PROTEINS IN HUMAN LEUKEMIA

      Blood
    100. RUTHARDT M; TESTA U; NERVI C; RIGANELLI D; FERRUCCI PF; GRIGNANI F; ALCALAY M; PUCCETTI E; GRIGNANI F; PESCHLE C; HOELZER D; PELICCI PG
      GENETIC DETERMINATION OF RETINOIC ACID RESPONSE IN ACUTE PROMYELOCYTIC LEUKEMIA

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 01:19:18